sanofi deal - potential, page-2

That for me is the single best aspect of this deal!!!

Lovenox was often talked about as a target Sanofi drug for Unifill as a means of trying to protect its market when it come off patent.

I had wrongly thought Sanofi had looked atbthe business case of using the Unifill to try and regain market share off cheaper generics.

So this deal says to me its about Sanofi extending their exclusive rights to Unifill in targetted marketds while they slowly roll it out to test the market and its uptake.

A very encouraging sign if UNS realise an audience in this market!!!!